Gilead Sciences Non-Controlling Interests remained flat by 0.0% to -$84.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from -$84.00M to -$84.00M. Over 5 years (FY 2020 to FY 2025), Non-Controlling Interests shows a downward trend with a 34.6% CAGR.
Changes reflect the ownership structure of consolidated entities and the performance of those specific subsidiaries.
Noncontrolling interests represent the portion of equity in a subsidiary that is not attributable, directly or indirectl...
Common in companies with complex organizational structures or joint ventures.
noncontrolling_interests| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $7.00M | $1.00M | -$5.00M | -$12.00M | -$21.00M | -$24.00M | -$31.00M | -$58.00M | -$64.00M | -$72.00M | -$84.00M | -$84.00M | -$84.00M | -$84.00M | -$84.00M | -$84.00M | -$84.00M | -$84.00M | -$84.00M |
| QoQ Change | — | -85.7% | -600.0% | -140.0% | -75.0% | -14.3% | -29.2% | -87.1% | -10.3% | -12.5% | -16.7% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | -400.0% | <-999% | -520.0% | -383.3% | -204.8% | -200.0% | -171.0% | -44.8% | -31.3% | -16.7% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
We use cookies for analytics. See our Privacy and Cookie Policy.